EC
CNMD icon

Elequin Capital’s CONMED CNMD Stock Holding History

Elequin Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3
Closed -$122 – 644
2025
Q4 		$122 Buy
+3
New +$131 ﹤0.01% 402
2025
Q1 		– Sell
-44
Closed -$3.01K – 385
2024
Q4 		$3.01K Sell
44
-23
-34% -$1.6K ﹤0.01% 433
2024
Q3 		$4.82K Buy
+67
New +$4.73K ﹤0.01% 294
2024
Q2 		– Sell
-90
Closed -$7.21K – 222
2024
Q1 		$7.21K Buy
+90
New +$8.02K ﹤0.01% 132
2023
Q3 		– Sell
-112
Closed -$15.2K – 442
2023
Q2 		$15.2K Buy
+112
New +$13.7K 0.01% 259
2022
Q3 		– Sell
-73
Closed -$7K – 583
2022
Q2 		$7K Buy
73
+23
+46% +$2.76K ﹤0.01% 267
2022
Q1 		$7K Buy
50
+29
+138% +$4.05K ﹤0.01% 193
2021
Q4 		$3K Buy
+21
New +$2.97K ﹤0.01% 22

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Elequin Capital's CNMD Position: Q1 2026 in Review

Elequin Capital sold out of CONMED (CNMD) in Q1 2026, closing a stake of 3 shares — an estimated $122 sold.

Elequin Capital first reported a position in CNMD in Q4 2021 and held it in 8 quarters. The position peaked at $15.2K in Q2 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Elequin Capital reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Elequin Capital sold 3 CONMED shares in Q1 2026, an estimated $122.
  • Elequin Capital first reported a position in CONMED in Q4 2021 and held it in 8 quarters.
  • Elequin Capital's CONMED position peaked at $15.2K in Q2 2023.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.